Table 3.
Statistical analysis of PHQ-9, GAD-7, ASDS and ISI in groups.
| Variables | G1(N = 837) | G2(N = 57) | G3(N = 660) | G4(N = 4087) | Total | H | Difference between groups |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G1-G2 | G1-G3 | G1-G4 | G2-G3 | G2-G4 | G3-G4 | |||||||
| PHQ-9 | 6.52 ± 6.14 | 8.74 ± 7.04 | 6.49 ± 6.02 | 5.92 ± 5.90 | 6.10 ± 5.97 | 20.520∗∗ | −2.352 | −0.147 | 2.637 | 2.277 | 3.165∗∗ | 2.568 |
| GAD-7 | 5.49 ± 5.37 | 7.51 ± 6.89 | 5.44 ± 5.39 | 4.75 ± 5.15 | 4.97 ± 5.25 | 31.126∗∗ | −1.798 | 0.147 | 3.981∗∗ | 1.839 | 2.978∗ | 3.418∗∗ |
| ASDS-Disassociation | 6.96 ± 3.16 | 8.33 ± 4.11 | 6.89 ± 2.92 | 6.73 ± 2.86 | 6.80 ± 2.93 | 14.481∗∗ | −2.886∗ | −0.542 | 1.250 | 2.657∗ | 3.317∗∗ | 1.803 |
| ASDS-Reexperiencing | 5.79 ± 2.51 | 6.54 ± 3.37 | 5.80 ± 2.46 | 5.42 ± 2.23 | 5.53 ± 2.33 | 48.556∗∗ | −1.628 | −0.496 | 4.815∗∗ | 1.428 | 3.041∗ | 4.970∗∗ |
| ASDS-Avoidance | 5.75 ± 3.10 | 7.42 ± 4.31 | 5.84 ± 2.93 | 5.51 ± 2.81 | 5.61 ± 2.90 | 25.270∗∗ | −3.177∗∗ | −1.465 | 1.695 | 2.598 | 3.742∗∗ | 3.350∗∗ |
| ASDS-Arousal | 10.79 ± 4.73 | 12.16 ± 5.47 | 10.51 ± 4.59 | 9.73 ± 4.09 | 10.00 ± 4.29 | 59.897∗∗ | −1.949 | 1.100 | 4.202∗∗ | 2.348 | 3.752∗∗ | 6.156∗∗ |
| ASDS | 29.29 ± 11.83 | 34.46 ± 14.75 | 29.05 ± 11.12 | 27.39 ± 10.38 | 27.94 ± 10.79 | 50.386∗∗ | −2.893∗ | −0.024 | 4.681∗∗ | 2.860∗ | 4.301∗∗ | 4.264∗∗ |
G1 = Group 1, G2 = Group 2, G3 = Group 3, G4 = Group 4. H, adjusted p-values (Kruskal–Wallis H Analysis) and mean ± SE for Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), Acute Stress Disorder Scale (ASDS) factor scores across groups; p < 0.05 is indicated by ∗, p < 0.01 is indicated by ∗∗.